Implantables, commonly known as prosthetics, are medical devices which are used to replace missing or abnormal body parts or organs. Various biomaterials are used for the development of implants such as metals, polymers, ceramics, and composites. The choice of material for implant development depends on application area, duration of implantation, biochemical properties of the material, and the material’s impact on tissues in the vicinity. Polymers have been used in the development of implants as these offer biocompatibility, tissue regeneration, flexibility, and strength. Polymers are widely used in orthopedic, esthetic, and cardiovascular implants beside which they are also been considered in implantable drug delivery devices for target specific drug delivery for the treatment of cancer and other disease indications. 

Polymers are used in the development of orthopedic implants such as spine implants, spinal spacers and discs, joint replacement implants, tendons, and ligaments. Increasing geriatric population is estimated to drive the demand for polymer-based orthopedic implants. It is estimated that more than 50% of orthopedic implants are used in patients aged 65 years and above. Moreover, with increasing demand for esthetics, the consumption of esthetic implants such as silicone-based breast implants and maxillofacial implants is projected to grow. Polymers are also used in cardiovascular implants such as drug eluting stents and artificial heart valves. According to an independent study conducted in the U.S., about 75% of coronary stents deployed in the U.S. was polymer-based drug eluting stents. Increase in the prevalence of cardiovascular diseases is expected to drive the growth of the polymer implantables market during the forecast period. However, there have been few adverse events in the recent years regarding the esthetic implants made with silicone, which has hampered the market growth. Additionally, inappropriate selection of materials, low-quality raw materials, and high cost of implants are the concerned areas of the polymer implantables market, which are estimated to restrain the market growth during the forecast period.

The global polymer implantables market is segmented on the basis of product, material, end-user, and region. In terms of product, the market can be segmented into orthopedic implants, cardiovascular implants, esthetic implants, dental implants, and others. The orthopedic implants segment can be classified into joint replacement implants and spinal implants. The others segment includes soft tissue repair products, hernia meshes, and surgical sutures. Growing incidence of cardiovascular diseases is estimated to drive the growth of the cardiovascular implants segment. On the basis of material, the market is segmented into polyethylene, silicone, polyurethane, polyketone, fluoropolymer, and others. The others segment includes bio absorbable polymers such as polylactic acid (PLA), polyglycolic acid (PGA), and polycaprolactone (PCL). Polyketone, such as PEEK, and polyethylene, such as ultra-high molecular weight polyethylene (UHMWPE) and high density polyethylene (HDPE), are widely used in the development of orthopedic implants. These two segments are projected to expand at a high growth rate during the forecast period. On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers (ASC), and others. Increasing base of ASCs and rising preference for minimally invasive procedures are estimated to drive the segment growth during the forecast period.

In terms of region, the global market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to hold a significant share of the global market due to high adoption of technology and increased health care expenditure. Europe is estimated to hold a prominent share of the global market and is anticipated to expand at a prominent growth rate, due to increasing geriatric population and developing healthcare infrastructure.

Major players operating in the global polymer implantables market include Boston Scientific Corporation, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Edwards Lifesciences Corporation, Abbott Laboratories, Terumo Corporation, Medtronic plc, Johnson & Johnson, and Straumann Holding AG.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Polymer Implantables Market

Pre Book